Health Adaptive Pacemaker Fails in HFpEF James Pereira Mar 9, 2023 NEW ORLEANS -- Using an adaptive pacemaker in patients… Read More...
Health Imbria Enrolls First Patient in the Phase 2 IMPROVE-DiCE Clinical Trial Evaluating Ninerafaxstat in… James Pereira Jan 9, 2023 BOSTON, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Imbria Pharmaceuticals, Inc., a clinical stage, cardiometabolic company… Read More...
Health American Society of Echocardiography Invests in Joint Research Initiative to Help Patients Suffering… James Pereira Sep 29, 2022 Durham, NC, Sept. 29, 2022 (GLOBE NEWSWIRE) -- The American Society of Echocardiography (ASE) is targeting its… Read More...
Health CPR During Abe Assassination; More Medicare Cuts; Too Little Salt and HFpEF James Pereira Jul 20, 2022 A physician bystander… Read More...
Health Late-breaking Results Show Efficacy for CCM in Patients With HFpEF James Pereira May 23, 2022 MADRID and MARLTON, N.J., May 23, 2022 (GLOBE NEWSWIRE) -- Impulse Dynamics, a global medical device company… Read More...
Health Dapagliflozin’s HFpEF Win; Angiograms of the HIV+; Side Effects of PCSK9 Inhibitors? James Pereira May 11, 2022 For heart failure patients… Read More...
Health Infertility History Linked to Increased Heart Failure Risk James Pereira Apr 19, 2022 says first author Emily Lau, MD, MPH, cardiologist and director of the Menopause, Hormones & Cardiovascular Clinic… Read More...
Health In HFpEF, Do MRA Users Get as Much Benefit From an SGLT2 Inhibitor? James Pereira Mar 22, 2022 Empagliflozin (Jardiance)… Read More...
Health Empagliflozin Also Shows Benefit for ‘True’ HFpEF Patients James Pereira Dec 14, 2021 At the American Heart Association (AHA)… Read More...
Health Peak VO2 Improved After Beta-Blocker Withdrawal in Some HFpEF Patients James Pereira Nov 16, 2021 Short-term withdrawal of… Read More...